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doi:10.1016/j.jtcvs.2004.01.035296 The Journal of Thoracic and CardioObjective: We sought to evaluate the medical and surgical outcome of tricuspid
regurgitation caused by flail leaflets.
Methods: We analyzed the cause, clinical presentation, outcome, and natural history
of 60 patients with tricuspid regurgitation caused by flail leaflets, a cause of mostly
severe and organic tricuspid regurgitation, diagnosed by means of echocardiography
between 1980 and 2000.
Results: The main cause was traumatic (62%). Clinical presentation was often
severe: 57% were symptomatic, 33% had a history of congestive heart failure, and
40% had a history of atrial fibrillation. Compared with expected survival of the US
matched population, excess mortality (39%  10% at 10 years or 4.5% yearly, P 
.01) was observed. Even patients asymptomatic at presentation experienced high
tricuspid-related event rates (at 10 years, 75%  15% had symptoms or heart
failure, atrial fibrillation, surgical intervention, or death). In those patients severe
enlargement of right-sided chambers was predictive of poor outcome (at 5 years:
86%  9% vs 39%  11%, P  .01) independent of cause (P  .31). The poor
medical outcome was further confirmed by high event rates (69% 9% at 15 years)
in the natural history beginning from the flail’s occurrence. Tricuspid operations
were performed in 33 patients (55% 7% at 5 years), with valve repair in 82%, low
mortality (3%), and, despite frequently refractory atrial fibrillation, symptomatic
improvement in 88%.
Conclusion: Tricuspid regurgitation caused by flail leaflets is a serious disease
associated with excess mortality and high morbidity. Tricuspid valve repair can
often be performed with low risk, allowing symptomatic improvement. These
results suggest that surgical intervention should be considered early in the course of
the disease before the occurrence of irreversible consequences.
Tricuspid regurgitation (TR) is a common Doppler echocardiographicfinding1 resulting either from intrinsic valve abnormalities (organicTR) or functional malcoaptation of structurally normal valves. De-spite this high prevalence, the effect of TR on clinical outcomeremains elusive for several reasons. First, mild TR is frequent evenin normal subjects, but severe TR is less frequent. Second, TR is
difficult to assess, and quantitative methods are only recently available.2 Third, the
prognostic significance of severe TR has been mainly evaluated in functional
3,4regurgitation. Functional TR is most common but is dynamic and changes with
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and severity of the underlying pulmonary hypertension re-
sponsible for the regurgitation. In contrast, organic TR is
due to permanent and organic valvular lesions and might
allow specific assessment of the outcome of the TR with
minimal confounding factors. Complicated courses with
intractable heart failure have been described,5-7 but other
reports stressed the fact that patients with severe TR can do
well for prolonged periods of time.8,9 Furthermore, the
tricuspid valve can be completely removed with reportedly
good long-term clinical tolerance,10,11 so that TR, even of a
marked degree, has the reputation of being well tolerated.
Because of these contradictory findings and the paucity of
natural history studies, the effect of severe TR on outcome
remains uncertain. This uncertainty is an impediment to the
clinical management of patients with TR, as emphasized in
most current practice guidelines, and although this condi-
tion can be treated with surgical intervention, operative
indications are not clearly defined.12
TR caused by flail leaflets is a permanent, organic, and
mostly severe TR13 and is reliably diagnosed by means of
2-dimensional echocardiography.14 However, there has
been no comprehensive study, and the experience regarding
this valve disease is limited to case reports or short series
involving less than 25 patients.13,15,16 Accordingly, we ex-
amined the causes, clinical presentations, and outcomes of
patients with tricuspid flail leaflets.
Methods
Study Population
Patients were included if they had tricuspid flail leaflets diagnosed
by means of 2-dimensional echocardiography between 1980 and
2000 in our institution. The cause of the valve disease was defined
on the basis of history and echocardiographic and surgical findings
if available. A history of severe chest trauma was required for the
diagnosis of traumatic (noniatrogenic) flail. Symptoms were clas-
sified according to the New York Heart Association grading.
Congestive heart failure was defined by using the Framingham
criteria,17 and recurrent episodes were noted. The TR was clini-
cally assessed on the basis of the presence of systolic murmur and
hepatic or jugular venous pulsatility. Patients were divided into 3
groups according to functional status. Symptomatic patients
(NHYA class II, congestive heart failure, or both) were included
in group I if there was no other reason for symptoms than TR and
in group II if associated conditions could have played a role in
symptoms. Asymptomatic patients (NHYA class I and no history
of congestive heart failure) formed group III. The diagnosis of
atrial fibrillation (AF) required electrocardiographic confirmation.
AF that either preceded the known occurrence of TR or was due to
another cause was not considered as related to TR. Follow-up
information was obtained through clinical records, postal surveys,
death certificates, and telephone calls to patients, relatives, or
physicians. If possible, the date of occurrence of TR was deter-
mined on the basis of clinical information, medical records, and
echocardiographic examinations.
The Journal of ThoraciEchocardiographic Methods
Comprehensive transthoracic echocardiography was consistently
performed throughout the study period. The diagnosis of flail
leaflet was based on failure of leaflet coaptation with rapid systolic
movement of the involved leaflet tip in the right atrium.5,18 TR was
assessed semiquantitatively in 4 grades (mild, moderate, moderate
to severe, and severe) on the basis of comprehensive assessment by
using pulsed-wave Doppler, color jet extent, hepatic venous flow
reversal, or quantitative methods.2,19 Assessment of right atrial and
ventricular dilatation was performed on the basis of a comprehen-
sive examination of these cavities from multiple views and clas-
sified into 4 grades (absent, mild, moderate, and severe) by expe-
rienced physicians. The size of other cardiac chambers provided
useful references for this assessment. Severe enlargement of right-
sided chambers was defined by a severe dilatation of the right
atrium, the right ventricle, or both cavities. Additionally, end-
systolic right atrial and end-diastolic right ventricular areas were
planimetered from a single-plane, apical, 4-chamber view to com-
pare right atrial and ventricular sizes between groups. Right ven-
tricular fractional area contraction was calculated. Areas were
normalized to body surface area and compared with those of 23
other patients with functional (nonflail) TR of mild or at most
moderate degree, as reference values.
Statistical Analysis
Data are presented as means  SD or percentages. Comparisons
between groups used analysis of variance, t tests, or 2 tests as
appropriate. The end points analyzed were total mortality, occur-
rence of symptoms or heart failure, occurrence of new AF (par-
oxysmal or chronic), and the composite end point of symptoms,
new AF, tricuspid surgery, or death. The clinical outcome after
diagnosis was analyzed overall and in subsets stratified by symp-
tomatic status at diagnosis. Patients operated on within 3 months of
diagnosis were considered as initially surgically managed, whereas
the other patients were considered initially conservatively man-
aged. The rates of mortality and of other end points were estimated
by using the Kaplan-Meier method, and differences between
groups were tested with the 2-sample log-rank test. Survival was
compared with the expected survival of the age- and sex-matched
white 1990 US population and tested with the 1-sample log-rank
test. Cox proportional-hazards analysis was performed to evaluate
predictors of outcome. The end points were analyzed starting at
diagnosis for analysis of clinical outcome after diagnosis or start-
ing at the date of occurrence of TR for analysis of natural history
of the disease.
Results
Cause and Clinical Presentation of Tricuspid Flail
Leaflets
Between 1980 and 2000, 60 patients with tricuspid flail
leaflets were identified by means of echocardiography. The
cause was mainly traumatic (n 37 [62%]), related to blunt
chest trauma (mostly motor vehicle accident) in 19 and to
iatrogenic chordal severing (mostly right ventricular biopsy)
in 18. Nontraumatic causes (n  23 [38%]) were myxoma-
tous (n 7 [12%]), infective endocarditis (n 5 [8%]), and
congenital (n  2 [3%]), and in 9 (15%) patients with
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fined, and these patients were considered idiopathic.
At diagnosis (Table 1), age was 51  26 years, 37
patients were men, 34 (57%) were symptomatic (New York
Heart Association class II), 20 (33%) had a history of
congestive heart failure, and 12 (20%) had recurrent con-
gestive heart failure. In 2 patients a right-to-left shunt
through a patent foramen ovale contributed to hypoxemia.
Twenty-four (40%) patients had a history of AF, and 15
(25%) were in AF at presentation. The 6 patients with a
history of preexisting chronic or paroxysmal AF unrelated
to the TR were excluded from subsequent analysis regard-
ing rhythm disturbance end points.
The flail segment involved the tricuspid anterior leaflet in
33 (55%) patients, the septal leaflet in 16 (27%) patients, the
posterior leaflet in 4 (7%) patients, and both the septal and
posterior leaflets in 1 (1%) patient, and it could not be
clearly defined in 6 (10%) patients. TR was assessed in all
patients clinically, in 56 by means of Doppler echocardiog-
raphy and in 13 by means of catheterization, and was
considered moderate in 5 (8%) patients, moderate to severe
in 6 (10%) patients, and severe in 49 (82%) patients. TR
velocity was 2.4 0.7 m/s, which is consistent with normal
pulmonary pressures. Thirty-five (58%) patients had severe
enlargement of right-sided chambers. Right atrial and ven-
tricular areas, measurable in 56 patients, were significantly
enlarged compared with those in the 23 patients (age, 64 
15 years) with mild-to-moderate functional TR (21  10 vs
14  5 cm2/m2, P  .001, and 23  10 vs 16  6 cm2/m2,
TABLE 1. Baseline clinical and echocardiographic charac
leaflets
Variables
Overall
population
N 60
Age (y) 51 26
Male sex (%) 62
Cause (%)
Traumatic, noniatrogenic 32
Traumatic, iatrogenic 30
History of atrial fibrillation (%) 40
Atrial fibrillation at presentation (%) 25
History of congestive heart failure (%) 33
Recurrent congestive heart failure (%) 20
Severe TR (%) 82
Right atrial area index (cm2/m2) 21 10
Right ventricular area index (cm2/m2) 23 10
Severe right-sided chamber enlargement 58
Right ventricular fractional area contraction (%) 41 12
Values are percentages of patients or means  SD.
TR, Tricuspid regurgitation.P  .005, respectively).
298 The Journal of Thoracic and Cardiovascular Surgery ● AuguGroup I (symptoms caused by TR) was composed of 23
patients, group II (symptoms with associated disease) was
composed of 11 patients, and group III (asymptomatic) was
composed of 26 patients. Two patients in group I had a
normally functioning mitral valve prosthesis. Associated
diseases in group II were restrictive cardiomyopathy (n 
3), congenital heart disease (n  3), chronic obstructive
pulmonary disease (n  2), left ventricular to right atrial
fistula (n  1), left ventricular dysfunction (n  1), and
lymphoma (n  1). Nine patients had previous heart trans-
plantation without significant signs of rejection and were
asymptomatic (group III). There were no age or sex differ-
ences between groups (Table 1), but patients in Group III
had less frequent AF or severe TR. Patients in group III had
smaller right-sided chamber sizes. In group III only 27%
had severe right-sided chamber enlargement, and right atrial
and ventricular areas were smaller than those in group I and
II patients but not different from those of control subjects
(16  6 vs 14  5 cm2/m2, P  .17, and 19  8 vs 16 
6 cm2/m2, P  .12).
Clinical Outcome
Follow-up was complete up to 2001 or death in 95%. Mean
follow-up time after diagnosis was 5.8  4.8 years and was
not different between groups (5.8  5.4, 3.9  3.5, and 6.5
 4.8 years, respectively; P  .37).
Mortality. Fifteen deaths occurred during follow-up,
corresponding to a mortality of 39%  10% at 10 years or
4.5% yearly, which was higher than expected in the US
tics of patients with tricuspid regurgitation caused by flail
Baseline characteristics by group
Group I
ptomatic
use of TR)
Group II (symptomatic
with associated
diseases)
Group III
(asymptomatic) P value
3 11 26
0 21 46 37 55 25 .58
8 64 73 .19
1 18 12 .01
4 36 50
2 64 19 .01
0 45 12 .03
8 82 0 .01
5 36 0 .01
6 82 69 .06
7 11 25 9 16 6 .01
5 8 28 15 19 8 .04
83 82 27 .01
8 17 43 8 43 8 .37teris
(sym
beca
2
5
4
6
5
3
4
3
9
2
2
3population (P  .01; Figure 1, A). Seven deaths were
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shock in 6 patients and infective endocarditis in 1 patient),
and only 1 posttransplantation patient died in refractory
heart failure caused by TR before scheduled surgical repair
(without any sign of significant rejection). Excluding pa-
tients from group II in whom associated diseases could have
affected survival, excess mortality in comparison with that
in the general population was also observed (36% 12% at
10 years or 3.8% yearly, P  .02; Figure 1, B), and 5 of 11
deaths were related to TR.
Surgery. Tricuspid surgery was performed in 33 patients
(55%  7% at 5 years), confirming the flail leaflet in all
cases. Indications were symptoms in 28 (85%) patients,
physician’s preference in 4 (12%) patients, and associated
coronary disease requiring surgical intervention in 1 (3%)
patient. There was no emergency procedure, but 23 inter-
ventions were performed within 3 months of diagnosis, and
30 were performed at our institution. The tricuspid valve
was repaired in 27 (82%) patients and replaced in 6 (18%)
patients. Surgical repair consisted mainly of placation-re-
section of the flail segment. Annular dilatation was cor-
rected with a De Vega annuloplasty (n 16) or a Carpentier
tricuspid ring (n  7). Subvalvular support by artificial
chordae was used in 4 patients. Tricuspid prostheses con-
sisted of 4 Carpentier-Edwards bioprotheses, 1 Saint-Jude,
and 1 Starr-Edwards. Additional procedures performed
were reduction right atrioplasty (52%), closure of a shunt at
the atrial level (45%), and coronary bypass grafting (6%).
One patient had an aortic valve replacement for moderate
aortic stenosis, and 1 patient had an obliteration of a post-
traumatic Valsalva aneurysm, with resuspension of the aor-
Figure 1. Long-term survival after diagnosis of TR caused by flail
leaflets compared with expected survival in the US matched
population. Excess mortality (4.5% yearly, P < .01) was observed
in the overall population (n  60) with tricuspid flail leaflets (A)
and after exclusion of patients with associated diseases contrib-
uting to symptoms (B; 3.8% yearly, P  .02).tic valve. Operative mortality occurred in 1 (3%) patient
The Journal of Thoraciwith associated coronary bypass because of sepsis and mul-
tiorgan failure. Only 2 (7%) of 27 patients undergoing repair
had residual TR of more than mild degree at predischarge
assessment. Symptomatic improvement was observed in
88%, but patients in AF before the operation remained so,
and among those in sinus rhythm, the incidence of new AF
(paroxysmal or chronic) was 32%  10% at 5 years and
45%  12% at 10 years (8.4% yearly).
Analyzed by group, 20 of 23 patients in group I under-
went tricuspid surgery. The 3 others were conservatively
managed, 2 because of advanced age, and 1 died before
scheduled surgical intervention. Five patients of group II
also underwent surgical repair, and 6 were conservatively
managed because of associated diseases. Eight patients of
group III (asymptomatic) underwent tricuspid surgery indi-
cated because of physician’s preference in 4, new symptoms
in 3, and associated coronary disease in 1.
Clinical outcome in asymptomatic patients. Fifteen pa-
tients of group III (58%) experienced symptoms, heart fail-
ure, new AF, surgical intervention, or died during follow-
up. Ten years after diagnosis, incidences of dyspnea or heart
failure, of new AF, and of the composite end point were
57%  22%, 14%  9%, and 75%  13%, respectively
(4.3%, 2.6%, and 13% yearly, respectively; Figure 2). Of
the posttransplantation patients, one had AF, one underwent
tricuspid surgery, and one died because of TR. Follow-up of
other posttransplantation patients was uneventful. Exclud-
ing them from analysis of outcome yielded similar event
rates, with a 10-year incidence of dyspnea or heart failure of
50% 25% and of the composite end point of 77% 13%.
Effect on outcome of right-sided chambers. Enlarge-
ment was evaluated in 2 subsets of patients, first in patients
with initial conservative management (n  37; no tricuspid
Figure 2. Clinical outcome after diagnosis of TR caused by flail
leaflets of asymptomatic patients. The Kaplan-Meier curve de-
picts the incidence of the combined end point of symptoms or
heart failure, new AF, cardiac surgery, or death.surgery within 3 months of diagnosis) and second in asymp-
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Surgery for Acquired Cardiovascular Disease Messika-Zeitoun et al
A
CDtomatic patients (group III). In both subsets the incidence of
the composite end point was markedly higher in patients
with severe enlargement of right-sided chambers (at 5 years:
86%  9% vs 39%  11%, P  .01, Figure 3; and 83% 
15% vs 33%  11%, P  .08, respectively). The associa-
tion of right ventricular fractional area contraction with
outcome did not reach statistical significance (P .12). The
higher rates of the composite end point in patients with
severe enlargement of right-sided chambers was confirmed
in both subsets (hazard ratio and 95% confidence interval)
after adjustment for age, sex, rhythm, and severity of TR
(hazard ratio of 1.76 and 95% confidence interval of 1.12-
2.85, P  .02, in patients with initial conservative manage-
ment and hazard ratio of 2.39 and 95% confidence interval
of 1.08-6.01, P  .03, in asymptomatic patients). Also, the
cause (iatrogenic or not) did not influence the outcome in
both subsets (P  .75 and P  .51, respectively).
Natural History
The natural history of the TR was analyzed in 34 patients in
whom the date of occurrence of the tricuspid flail could be
specified and excluding group II (associated diseases) pa-
tients. The cause was iatrogenic in 14 patients and noniatro-
genic in 20 patients. In those 34 patients, the flail leaflet
occurred at the age of 38  24 years and preceded by 12 
16 years the presentation at our institution. Twelve (35%)
patients were seen within 1 year after occurrence of the flail.
Twenty-eight (82%) patients experienced dyspnea, conges-
tive heart failure, or new AF; required tricuspid surgery; or
Figure 3. Clinical outcome after diagnosis of TR caused by flail
leaflets according to the degree of right-sided chamber enlarge-
ment. The Kaplan-Meier curves depict the incidence of the com-
bined end point of symptoms or heart failure, new AF, cardiac
surgery, or death in patients initially conservatively managed.
Note that patients with severe right-sided chamber enlargement
had a higher incidence of events.died during the course of the disease. Incidences of symp-
300 The Journal of Thoracic and Cardiovascular Surgery ● Augutoms or heart failure, AF, and the composite end point 15
years after occurrence of the flail tricuspid leaflet were 56%
 11%, 34%  12%, and 69%  9%, respectively (4.4%,
2.8%, and 6.5% yearly, respectively; Figure 4). Even after
exclusion of patients undergoing transplantation, the event
rate remained high (69%  9%). The composite end point
rate was not different in iatrogenic and noniatrogenic flail
leaflets (79%  17% vs 65%  11% at 15 years, P  .54).
Discussion
Isolated organic TR is infrequent. We report herein the first
sizable series of patients with tricuspid flail leaflets. Our
study shows that the cause was mostly traumatic, and the
clinical presentation was often severe, despite the usually
normal pulmonary pressure. The clinical outcome after di-
agnosis exhibited excess mortality and high morbidity dur-
ing follow-up. Even patients asymptomatic at presentation
experienced high tricuspid-related event rates, predicted by
severe enlargement of right-sided chambers on baseline
echocardiography, independent of the cause. This poor out-
come was also confirmed by the natural history beginning
from the date of occurrence of the flail. Surgical repair of
the tricuspid valve is generally feasible, with low operative
mortality and marked symptomatic improvement. However,
because surgical intervention is mostly performed at an
advanced stage, AF is often refractory. Therefore TR caused
by flail leaflets is a serious disease characterized over time
by a cumulative high rate of events irrespective of its cause,
suggesting that an operation should be considered early in
Figure 4. Natural history after occurrence of TR caused by flail
leaflets in patients without associated diseases contributing to
symptoms. The Kaplan-Meier curves depict the incidence of new
AF (2.8% yearly), class III or IV symptoms or congestive heart
failure (Sx or CHF, 4.4% yearly), and the composite end point of
first occurrence of symptoms or heart failure, new AF, tricuspid
surgery, or death (6.5% yearly).its course.
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Isolated organic TR has the reputation of being well toler-
ated, but there has been no comprehensive study, and case
reports have provided contradictory data on outcome.5-11
TR caused by flail leaflets has, for outcome analysis, the
unique advantages of being easily diagnosed by means of
echocardiography and of being frequently associated with
large volume overload, despite usually normal right ventric-
ular pressure,13 as noted in the present study. Chronic vol-
ume overload leads to adverse right atrial, ventricular, and
hemodynamic consequences20 compounded by occasional
right-to-left atrial shunting contributing to hypoxemia.21
These adverse consequences lead to functional impair-
ment,22 heart failure, and AF. Because TR is often clinically
unsuspected, patients are often given a diagnosis at an
advanced stage, with frequent symptoms or congestive heart
failure, AF, and right-sided chamber dilatation. The serious
nature of TR caused by flail leaflets is also demonstrated by
the excess mortality observed in comparison with expected
mortality. This mediocre outcome is confirmed after exclu-
sion of patients in whom associated diseases could have
affected prognosis and in patients asymptomatic at presen-
tation and is independent of the cause of the flail. Asymp-
tomatic patients at presentation exhibited a high incidence
of tricuspid-related events after diagnosis, with a 10-year
75% rate of severe symptoms or heart failure, AF, death, or
need for cardiac surgery. We were also able to define the
clinical outcome not only from the date of presentation but
also from the date of occurrence of the valve lesion. This
natural history analysis showed that the 15-year event rate
(symptoms, heart failure, AF, surgical intervention, or
death) was high (69% or 6.5% yearly), even after exclusion
of posttransplantation patients. This rate is particularly im-
portant because patients are usually young at occurrence of
this mostly posttraumatic lesion, in contrast to the mostly
degenerative mitral flail leaflets.23 Hence severe complica-
tions occur when patients are middle aged and seriously
affect their life expectancy. The progression to clinical
complications parallels the pattern of volume overload–
related chamber and annular enlargement,24 leading to in-
creasing TR25 and further volume overload. Thus TR
caused by flail leaflets is a progressive and serious disease
with definite mortality and morbidity risk.
Clinical Implications
Cause of tricuspid flail leaflets is, contrary to that of mitral
flail leaflets,23 mainly traumatic. Because clinical diagnosis
is difficult, after potential tricuspid trauma, Doppler echo-
cardiography offers the opportunity of early diagnosis14 and
close follow-up.
The results of our study suggest that early rather than late
surgical approach is warranted. Surgical intervention is re-
quired in a high proportion of patients, entails low operative
The Journal of Thoracimortality and high probability of valve repair, and provides
symptomatic improvement. However, because operations
are usually performed late in the course of the disease, AF
is often refractory. Therefore in view of the severe conse-
quences of TR caused by flail leaflets, surgical intervention
for symptomatic patients should be considered before oc-
currence of intractable heart failure. For asymptomatic pa-
tients, severe enlargement of right-sided chambers predicts
poor outcome, and patients with such enlargement should
be closely monitored and considered early for surgical in-
tervention. In asymptomatic patients without severe right-
sided chamber enlargement, TR and right ventricular dys-
function might be progressive,26 and close follow-up is
warranted. Thus the echocardiographic finding of tricuspid
flail leaflets implies a high risk of long-term tricuspid-
related complications and echoes recent data suggesting that
severe TR, even of functional cause, might have dire out-
come implications.22,27 Hence severe TR, particularly that
caused by flail leaflets, is a serious and progressive disease,
and patients should be warned about the need for close
follow-up and be considered early for surgical repair.
Limitations
The cause of tricuspid flail leaflets is not uniform, but the
shared mechanism of TR translates into similar outcomes
irrespective of cause. Patients with associated conditions, in
whom prognosis might not be totally dependent on the TR,
were separately analyzed. Furthermore, complications ob-
served in posttransplantation patients were TR related in the
present series. Even when these patients were excluded
from analysis, event rates remained high. Therefore cause
and associated conditions do not appear to bias the assess-
ment of the TR effect on outcome.
Referral bias cannot be ruled out as affecting the ob-
served outcome. However, a high incidence of complica-
tions was also observed in patients asymptomatic at presen-
tation and when the entire natural history was analyzed.
Treatment was not randomly assigned, so that the benefit of
surgical intervention cannot be definitively proved in
asymptomatic patients with severe right-sided chamber en-
largement. However, the excellent surgical results with low
mortality and high repair rates compare well with the over-
all excess mortality and the high incidence rates of compli-
cations observed in these patients. The frequency of post-
operative AF is, in our opinion, not contradicting the benefit
of surgical repair but rather suggesting that patients should
be operated on before the occurrence of irreversible cavity
enlargement.
Severe right-sided enlargement predictive of outcome
was judged from comprehensive multiview echocardiogra-
phy and confirmed on the basis of monoplane quantitative
measurements. The right ventricular function-outcome as-
28sociation, which was not significant, possibly because of
c and Cardiovascular Surgery ● Volume 128, Number 2 301
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For that purpose, 3-dimensional quantitative measurement
might be useful in patients with TR.
A maze procedure was performed in only 2 patients, and
we cannot draw any conclusions. However, such a proce-
dure might usefully complement the tricuspid surgery and
needs to be further evaluated.
Conclusion
TR caused by flail leaflets is most often posttraumatic, and
clinical presentation is severe, with outcome characterized
by excess mortality and high morbidity. This severe out-
come is confirmed by natural history analysis from the time
of occurrence of the lesion and suggests that severe TR is a
serious disease characterized over time by a cumulative
high rate of complications. Tricuspid surgery is often re-
quired and can be performed with low operative mortality
and high probability of valve repair and symptomatic im-
provement. Often refractory AF suggests that surgical in-
tervention should be considered earlier before occurrence of
intractable heart failure, particularly in patients with dilata-
tion of right-sided chambers.
References
1. Singh J, Evans J, Levy D, et al. Prevalence and clinical determinants
of mitral, tricuspid and aortic regurgitation. Am J Cardiol. 1999;83:
897-902.
2. Tribouilloy CM, Enriquez-Sarano M, Bailey KR, Tajik AJ, Seward JB.
Quantification of tricuspid regurgitation by measuring the width of the
vena contracta with Doppler color flow imaging: a clinical study. J Am
Coll Cardiol. 2000;36:472-8.
3. Koelling TM, Aaronson KD, Cody RJ, Bach DS, Armstrong WF.
Prognostic significance of mitral regurgitation and tricuspid regurgi-
tation in patients with left ventricular systolic dysfunction. Am Heart J.
2002;144:524-9.
4. Hung J, Koelling T, Semigran MJ, Dec GW, Levine RA, Di Salvo TG.
Usefulness of echocardiographic determined tricuspid regurgitation in
predicting event-free survival in severe heart failure secondary to
idiopathic-dilated cardiomyopathy or to ischemic cardiomyopathy.
Am J Cardiol. 1998;82:1301-3.
5. van Son JA, Danielson GK, Schaff HV, Miller FA Jr. Traumatic
tricuspid valve insufficiency. Experience in thirteen patients. J Thorac
Cardiovasc Surg. 1994;108:893-8.
6. Almeida M, Canada M, Neves J, et al. Longstanding traumatic tricus-
pid regurgitation with severe right ventricular failure. J Heart Valve
Dis. 1997;6:642-6.
7. Leszek P, Zielinski T, Rozanski J, Klisiewicz A, Korewicki J. Trau-
matic tricuspid valve insufficiency: case report. J Heart Valve Dis.
2001;10:545-7.
8. Morgan JR, Forker AD. Isolated tricuspid insufficiency. Circulation.
1971;43:559-64.
9. Croxson MS, O’Brien KP, Lowe JB. Traumatic tricuspid regurgitation.
Long-term survival. Br Heart J. 1971;33:750-5.
10. Arbulu A, Holmes RJ, Asfaw I. Tricuspid valvulectomy without302 The Journal of Thoracic and Cardiovascular Surgery ● Augureplacement. Twenty years’ experience. J Thorac Cardiovasc Surg.
1991;102:917-22.
11. Arbulu A, Holmes RJ, Asfaw I. Surgical treatment of intractable
right-sided infective endocarditis in drug addicts: 25 years experience.
J Heart Valve Dis. 1993;2:129-39.
12. Bonow R, Carabello B, DeLeon A, et al. ACC/AHA guidelines for the
management of patients with valvular heart disease. Circulation. 1998;
98:1949-84.
13. Tucker PA 2nd, Jin BS, Gaos CM, Radovancevic B, Frazier OH,
Wilansky S. Flail tricuspid leaflet after multiple biopsies following
orthotopic heart transplantation: echocardiographic and hemodynamic
correlation. J Heart Lung Transplant. 1994;13:466-72.
14. Miller FA Jr, Seward JB, Gersh BJ, Tajik AJ, Mucha P Jr. Two-
dimensional echocardiographic findings in cardiac trauma. Am J Car-
diol. 1982;50:1022-7.
15. Hausen B, Albes JM, Rohde R, Demertzis S, Mugge A, Schafers HJ.
Tricuspid valve regurgitation attributable to endomyocardial biopsies
and rejection in heart transplantation. Ann Thorac Surg. 1995;59:1134-
40.
16. Gayet C, Pierre B, Delahaye JP, Champsaur G, Andre-Fouet X, Rueff
P. Traumatic tricuspid insufficiency. An underdiagnosed disease.
Chest. 1987;92:429-32.
17. McKee P, Castelli W, McNamara P, Kannel W. The natural history of
congestive heart failure: the Framingham Study. N Engl J Med. 1971;
285:1441-6.
18. Reddy SC, Rath GA, Ziady GM, Matesic C, Kormos R. Tricuspid flail
leaflets after orthotopic heart transplant: a new complication of endo-
myocardial biopsy. J Am Soc Echocardiogr. 1993;6:223-6.
19. Tunon J, Cordoba M, Rey M, et al. Assessment of chronic tricuspid
regurgitation by colour Doppler echocardiography: a comparison with
angiography in the catheterization room. Eur Heart J. 1994;15:1074-
84.
20. Williams MJ, Lee MY, DiSalvo TG, et al. Biopsy-induced flail tricus-
pid leaflet and tricuspid regurgitation following orthotopic cardiac
transplantation. Am J Cardiol. 1996;77:1339-44.
21. Chiu WC, Shindler DM, Scholz PM, Boyarsky AH. Traumatic tricus-
pid regurgitation with cyanosis: diagnosis by transesophageal echo-
cardiography. Ann Thorac Surg. 1996;61:992-3.
22. Groves PH, Lewis NP, Ikram S, Maire R, Hall RJ. Reduced exercise
capacity in patients with tricuspid regurgitation after successful mitral
valve replacement for rheumatic mitral valve disease. Br Heart J.
1991;66:295-301.
23. Ling H, Enriquez-Sarano M, Seward J, et al. Clinical outcome of
mitral regurgitation due to flail leaflets. N Engl J Med. 1996;335:1417-
23.
24. Iga K, Konishi T, Matsumura T, Miyamoto T, Kijima K, Gen H.
Markedly enlarged right atrium associated with physical signs of
tricuspid regurgitation—a cause of congestive heart failure in the
elderly. Jpn Circ J. 1994;58:683-8.
25. Sagie A, Schwammenthal E, Padial LR, Vazquez de Prada JA, Wey-
man AE, Levine RA. Determinants of functional tricuspid regurgita-
tion in incomplete tricuspid valve closure: Doppler color flow study of
109 patients. J Am Coll Cardiol. 1994;24:446-53.
26. Mukherjee D, Nader S, Olano A, Garcia MJ, Griffin BP. Improvement
in right ventricular systolic function after surgical correction of iso-
lated tricuspid regurgitation. J Am Soc Echocardiogr. 2000;13:650-4.
27. Sagie A, Schwammenthal E, Newell JB, et al. Significant tricuspid
regurgitation is a marker for adverse outcome in patients undergoing
percutaneous balloon mitral valvuloplasty. J Am Coll Cardiol. 1994;
24:696-702.
28. Zornoff LA, Skali H, Pfeffer MA, et al. Right ventricular dysfunction
and risk of heart failure and mortality after myocardial infarction. J Am
Coll Cardiol. 2002;39:1450-5.st 2004
